Carrie Ballenger, APRN
Psychiatric/Mental Health · Greenville, SCNPI 1275175093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 561 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 561 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Lundbeck LLC$727
- Takeda Pharmaceuticals U.S.A., Inc.$678
- Axsome Therapeutics, Inc.$599
- plus $5K from 25 others
What the payments were for
- Food & beverage$10,691100%
- Education$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $1,242 |
| AbbVie | 90 | $1,172 |
| Otsuka America Pharmaceutical, Inc. | 62 | $1,102 |
| Lundbeck LLC | 35 | $727 |
| Takeda Pharmaceuticals U.S.A., Inc. | 39 | $678 |
| Axsome Therapeutics, Inc. | 28 | $599 |
| Supernus Pharmaceuticals, Inc. | 7 | $540 |
| Corium, LLC | 28 | $530 |
| Tris Pharma Inc | 23 | $505 |
| Alkermes, Inc. | 17 | $468 |
| Vanda Pharmaceuticals Inc. | 21 | $459 |
| Sunovion Pharmaceuticals Inc. | 18 | $394 |
| Bausch Health US, LLC | 20 | $387 |
| Neos Therapeutics, LP | 27 | $365 |
| Johnson & Johnson | 14 | $272 |
| Teva Pharmaceuticals USA, Inc. | 11 | $238 |
| Noven Therapeutics, LLC | 11 | $219 |
| Eisai Inc. | 14 | $135 |
| Merck | 8 | $122 |
| Ironshore Pharmaceuticals Inc. | 7 | $122 |
| Almatica Pharma LLC | 7 | $122 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Neurocrine Biosciences, Inc. | 3 | $46 |
| Harmony Biosciences LLC | 2 | $43 |
| Tonix Medicines, Inc. | 2 | $40 |
| Avanir Pharmaceuticals, Inc. | 2 | $34 |
| Acadia Pharmaceuticals Inc | 2 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| Adlon Therapeutics L.p. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,738 in reported general payments places this provider in the 95th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 12 | $86,452 |
| VraylarCariprazine Hcl | 26 | $36,265 |
| Vilazodone Hcl | 16 | $2,383 |
| Paroxetine Hcl | 28 | $2,149 |
| Duloxetine Hcl | 71 | $1,410 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $1,203 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $1,199 |
| Aripiprazole | 51 | $1,018 |
| Ziprasidone Hcl | 17 | $744 |
| Mirtazapine | 47 | $677 |
| Buspirone Hcl | 40 | $649 |
| Doxepin Hcl | 13 | $646 |
| Bupropion XlBupropion Hcl | 17 | $568 |
| Clonazepam | 90 | $500 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $238 | $86,45212 claims |
| AbbVieVraylar | $1,172 | $36,26526 claims |
| Almatica Pharma LLCSertraline Hcl | $122 | $25916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Greenville
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- William HendricksGreenville$13K
- Gregory SmithGreenville$9K
- Svetlana RobinsonGreenville$8K
- Jared CarboneGreenville$7K
- Anglique RichGreenville$6K
- Matthew HendricksGreenville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.